Lifecore Biomedical (Lifecore Biomedical) Earnings Yield (Joel Greenblatt) % : -13.81% (As of May. 2023)

Lifecore Biomedical Earnings Yield (Joel Greenblatt) % Chart

Lifecore Biomedical Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	May23
Earnings Yield (Joel Greenblatt) %		Get a 7-Day Free Trial					2.01	-4.88	-3.69	-1.20	-13.81

Lifecore Biomedical Quarterly Data
	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23
Earnings Yield (Joel Greenblatt) %	Get a 7-Day Free Trial															-1.20	-1.75	-4.99	-9.18	-13.81

Competitive Comparison of Lifecore Biomedical's Earnings Yield (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifecore Biomedical's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Earnings Yield (Joel Greenblatt) % falls into.

Lifecore Biomedical Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Lifecore Biomedicals Earnings Yield (Joel Greenblatt) for the fiscal year that ended in May. 2023 is calculated as

Lifecore Biomedical's EBIT for the trailing twelve months (TTM) ended in May. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-50.8 Mil.

Lifecore Biomedical  (NAS:LFCR) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.

Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.

Lifecore Biomedical Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifecore Biomedical (Lifecore Biomedical) Business Description